Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C

Controlling the false discovery rate in behavior genetics research

Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146 · see citing works

Separation of leukocytes from blood and bone marrow

Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 2,724 · see citing works

The many roles of chemokines and chemokine receptors in inflammation

Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · see citing works

Hepatitis C

Schaff, Z., & Csmos, G. (1994) · Cited by 1,869 · see citing works

C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells

Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,209 · see citing works

Separation of leukocytes from blood and bone marrow. Introduction.

Bøyum, A. (1968) · PubMed · Cited by 694 · see citing works

An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection

Cabrera, R., Tu, Z., Xu, Y., Firpi, R. J., Rosen, H. R., Liu, C., & Nelson, D. R. (2004) · Hepatology · doi:10.1002/hep.20454 · Cited by 561 · see citing works

From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells

Shevach, E. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.003 · Cited by 549 · see citing works

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 530 · see citing works

T Cells with a CD4 + CD25 + Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8 + T Cells during Chronic Hepatitis C Virus Infection

Boettler, T., Spangenberg, H. C., Neumann‐Haefelin, C., Panther, E., Urbani, S., Ferrari, C. I., Blum, H. E., von Weizsäcker, F., & Thimme, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7860-7867.2005 · Cited by 404 · see citing works

Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection

Sugimoto, K., Ikeda, F., Stadanlick, J. E., Nunes, F. A., Alter, H. J., & Chang, K. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.026 · Cited by 369 · see citing works

Flying Under the Radar: The Immunobiology of Hepatitis C

Dustin, L. B., & Rice, C. M. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313 · see citing works

Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis

Zimmermann, H. W., Seidler, S., Gaßler, N., Nattermann, J., Luedde, T., Trautwein, C., & Tacke, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021381 · Cited by 276 · see citing works

Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8 + T Cells during Persistent Hepatitis C Virus Infection

Rushbrook, S., Ward, S. M., Unitt, E., Vowler, S. L., Lucas, M., Klenerman, P., & Alexander, G. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7852-7859.2005 · Cited by 274 · see citing works

Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells

Wang, R., Kozhaya, L., Mercer, F. K., Khaitan, A., Fujii, H., & Unutmaz, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901965106 · Cited by 252 · see citing works

Detection of Functionally Altered Hepatitis C Virus–Specific Cd4+ T Cells in Acute and Chronic Hepatitis C

Ulsenheimer, A., Gerlach, J. T., Gruener, N. H., Jung, M., Schirren, C.-A., Schraut, W., Zachoval, R., Pape, G. R., & Diepolder, H. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50194 · Cited by 220 · see citing works

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

Asselah, T., Bièche, I., Laurendeau, I., Paradis, V., Vidaud, D., Degott, C., Martinot-Peignoux, M., Bédossa, P., Valla, D. C., Vidaud, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.010 · Cited by 163 · see citing works

Identification and In Vitro Expansion of Functional Antigen-Specific CD25 + FoxP3 + Regulatory T Cells in Hepatitis C Virus Infection

Ebinuma, H., Nakamoto, N., Li, Y., Price, D. A., Emma Gostick, D., Levine, B. L., Tobias, J. W., Kwok, W. W., & Chang, K. (2008) · Journal of Virology · doi:10.1128/jvi.01548-07 · Cited by 160 · see citing works

Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection

Ward, S. M., Fox, B. C., Brown, P. J., Worthington, J., Fox, S. B., Chapman, R. W., Fleming, K. A., Banham, A. H., & Klenerman, P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.023 · Cited by 151 · see citing works

Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis

Claassen, M. A. A., de Knegt, R. J., Tilanus, H. W., Janssen, H. L. A., & Boonstra, A. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.013 · Cited by 150 · see citing works

Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis

Muhanna, N., Doron, S., Wald, O., Horani, A., Eid, A., Pappo, O., Friedman, S. L., & Safadi, R. (2008) · Hepatology · doi:10.1002/hep.22413 · Cited by 147 · see citing works

Increased hepatitis C virus (HCV)-specific CD4+CD25 + regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normalversusabnormal alanine aminotransferase levels

Bolacchi, F., Sinistro, A., Ciaprini, C., Demin, F., Capozzi, M., Carducci, F. I. C., Drapeau, C. M. J., Rocchi, G., & Bergamini, A. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03048.x · Cited by 142 · see citing works

Both β‐actin and GAPDH are useful reference genes for normalization of quantitative RT‐PCR in human FFPE tissue samples of prostate cancer

Mori, R., Wang, Q., Danenberg, K. D., Pinski, J., & Danenberg, P. V. (2008) · The Prostate · doi:10.1002/pros.20815 · Cited by 126 · see citing works

Tim-3 Pathway Controls Regulatory and Effector T Cell Balance during Hepatitis C Virus Infection

Moorman, J. P., Wang, J. M., Zhang, Y., Xiao, J., Cheng, J., Wu, X. Y., Jia, Z., Wang, K. S., & Yao, Z. Q. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200162 · Cited by 105 · see citing works

Differential Regulatory Capacity of CD25+ T Regulatory Cells and Preactivated CD25+ T Regulatory Cells on Development, Functional Activation, and Proliferation of Th2 Cells

Stassen, M., Jonuleit, H., Müller, C., Klein, M., Richter, C., Bopp, T., Schmitt, S., & Schmitt, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.267 · Cited by 98 · see citing works

Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis

Napoli, J., Bishop, G. A., & McCaughan, G. W. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90128-7 · Cited by 94 · see citing works

Functional Suppression by FoxP3+CD4+CD25highRegulatory T Cells during Acute Hepatitis C Virus Infection

Smyk‐Pearson, S., Golden‐Mason, L., Klarquist, J. S., Burton, J. R., Tester, I. A., Wang, C. C., Culbertson, N. E., Vandenbark, A. A., & Rosen, H. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/523651 · Cited by 91 · see citing works

Human CD4 + FOXP3 + regulatory T cells produce CXCL8 and recruit neutrophils

Himmel, M. E., Crome, S. Q., Ivison, S. M., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2010) · European Journal of Immunology · doi:10.1002/eji.201040459 · Cited by 85 · see citing works

Regulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus Infection

Wagoner, J., Austin, M., Green, J., Imaizumi, T., Casola, A., Brasier, A. R., Khabar, K. S. A., Wakita, T., Gale, M., & Polyak, S. J. (2006) · Journal of Virology · doi:10.1128/jvi.01411-06 · Cited by 77 · see citing works

Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-α and interleukin 8

Radkowski, M., Bednarska, A., Horban, A., Stańczak, J. J., Wilkinson, J., Adair, D. M., Nowicki, M., Rakela, J., & Laskus, T. (2004) · Journal of General Virology · doi:10.1099/vir.0.19491-0 · Cited by 77 · see citing works

HCV ‐infected hepatocytes drive CD 4+ CD 25+ F oxp3+ regulatory T ‐cell development through the T im‐3/ G al‐9 pathway

Xiao, J., Cheng, J., Wang, J. M., Wu, X. Y., Niki, T., Hirashima, M., Moorman, J. P., & Yao, Z. Q. (2012) · European Journal of Immunology · doi:10.1002/eji.201242768 · Cited by 76 · see citing works

An Altered Cellular Response to Interferon and Up-Regulation of Interleukin-8 Induced by the Hepatitis C Viral Protein NS5A Uncovered by Microarray Analysis

Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D. E., Hanash, S., Bréchot, C., & Beretta, L. (2002) · Virology · doi:10.1006/viro.2002.1373 · Cited by 72 · see citing works

Interleukin-8 and hIRH (SDF1-α/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C

Shimoda, K., Begum, N. A., Shibuta, K., Mori, M., Bonkovsky, H. L., Banner, B. F., & Barnard, G. F. (1998) · Hepatology · doi:10.1002/hep.510280116 · Cited by 63 · see citing works

Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis

Stürm, N., Thelu, M. A., Camous, X., Dimitrov, G., Ramzan, M., Dufeu‐Duchesne, T., Bonorino, P., Guillermet, C., Brambilla, E. M., Arvers, P., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.024 · Cited by 60 · see citing works

The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8

Clément, S., Pascarella, S., Conzelmann, S., Gonelle‐Gispert, C., Guilloux, K., & Negro, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.035 · Cited by 60 · see citing works

Quantitative analysis of the level of p53 and p21(WAF1) mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate.

Węglarz, L., Molin, I., Orchel, A., Parfiniewicz, B., & Dzierżewicz, Z. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3348 · Cited by 60 · see citing works

Circulating Toll‐like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C

WANG, J., Zhang, Y., WEI, X., Li, J., Nan, X.-P., Yu, H., LI, Y., Wang, P., & Bai, X. (2010) · Apmis · doi:10.1111/j.1600-0463.2010.02586.x · Cited by 54 · see citing works

Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2

Coenen, M., Nischalke, H. D., Krämer, B., Langhans, B., Glässner, A., Schulte, D., Körner, C., Sauerbruch, T., Nattermann, J., & Spengler, U. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.78 · Cited by 50 · see citing works

Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C

Langhans, B., Braunschweiger, I., Arndt, S., Schulte, W., Satoguina, J., Layland, L. E., Vidovic, N., Hoerauf, A. M., Oldenburg, J., Sauerbruch, T., et al. (2010) · Clinical Science · doi:10.1042/cs20090661 · Cited by 45 · see citing works

FOXP3 Expression in Hepatitis C Virus–Specific CD4+ T Cells During Acute Hepatitis C

Heeg, M. H. J., Ulsenheimer, A., Grüner, N. H., Zachoval, R., Jung, M., Gerlach, J. T., Raziorrouh, B., Schraut, W., Horster, S., Kauke, T., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.059 · Cited by 41 · see citing works

Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells

Balasubramanian, A., Munshi, N., Koziel, M. J., Hu, Z., Liang, T. J., Groopman, J. E., & Ganju, R. K. (2005) · Journal of General Virology · doi:10.1099/vir.0.81056-0 · Cited by 39 · see citing works

Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis.

Masumoto, T., Ohkubo, K., Yamamoto, K. I., Ninomiya, T., Abe, M., Akbar, S. M., Michitaka, K., Horiike, N., & Onji, M. (1998) · PubMed · Cited by 32 · see citing works

Ribavirin Exerts Differential Effects on Functions of Cd4+ Th1, Th2, and Regulatory T Cell Clones in Hepatitis C

Langhans, B., Nischalke, H. D., Arndt, S., Braunschweiger, I., Nattermann, J., Sauerbruch, T., & Spengler, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042094 · Cited by 29 · see citing works

Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution

Perrella, A., Vitiello, L., Atripaldi, L. G., Conti, P., Sbreglia, C., Altamura, S., Patarino, T., Vela, R., Morelli, G., Bellopede, P., et al. (2006) · Gut · doi:10.1136/gut.2006.099887 · Cited by 29 · see citing works

Nonstructural Proteins 4A and 4B of Hepatitis C Virus Transactivate the Interleukin 8 Promoter

Kadoya, H., Nagano‐Fujii, M., Deng, L., Nakazono, N., & Hotta, H. (2005) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2005.tb03728.x · Cited by 29 · see citing works

Hepatitis C virus non-structural protein-2 activates CXCL-8 transcription through NF-κB

Oem, J., Jackel‐Cram, C., Li, Y.-P., Kang, H., Zhou, Y., Babiuk, L. A., & Liu, Q. (2007) · Archives of Virology · doi:10.1007/s00705-007-1103-1 · Cited by 28 · see citing works

Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients

Mahmood, S. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00136-5 · Cited by 28 · see citing works

Pathogenese der Leberfibrose: Regulation von hepatischen Sternzellen durch Chemokine

Wasmuth, H. E., & Weiskirchen, R. (2010) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0028-1109933 · Cited by 26 · see citing works

Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells

Wertheimer, A. M., Polyak, S. J., Leistikow, R. L., & Rosen, H. R. (2007) · Hepatology · doi:10.1002/hep.21637 · Cited by 20 · see citing works

Antiviral action of interferon‐α against hepatitis C virus replicon and its modulation by interferon‐γ and interleukin‐8

Jia, Y.-T., Wei, L., Jiang, D., Wang, J., Xu, C., & Fei, R. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04957.x · Cited by 19 · see citing works

Hepatitis C Virus Core Protein and Hepatitis Activity Are Associated through Transactivation of Interleukin‐8

Hoshida, Y., Kato, N., Yoshida, H., Wang, Y., Tanaka, M., Goto, T., Otsuka, M., Taniguchi, H., Moriyama, M., Imazeki, F., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/430924 · Cited by 18 · see citing works

Hepatic stellate cells as key target in liver fibrosis

Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · see citing works

Liver fibrosis and repair: Immune regulation of wound healing in a solid organ

Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310 · see citing works

Hepatic inflammation and fibrosis: Functional links and key pathways

Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972 · see citing works

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma

Fu, Y., Liu, S., Zeng, S., & Shen, H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1396-4 · Cited by 393 · see citing works

Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions

Wilson, G. K., Tennant, D. A., & McKeating, J. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.025 · Cited by 201 · see citing works

Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion

Wang, D., Yang, L., Yue, D., Cao, L., Li, L., Wang, D., Ping, Y., Shen, Z., Zheng, Y., Wang, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.040 · Cited by 183 · see citing works

Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis

Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar7754 · Cited by 155 · see citing works

The Endothelium as a Driver of Liver Fibrosis and Regeneration

Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández–Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 147 · see citing works

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

Langhans, B., Nischalke, H. D., Krämer, B., Dold, L., Lutz, P. L., Mohr, R. U., Vogt, A., Toma, M. I., Eis‐Hübinger, A. M., Nattermann, J., et al. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02427-4 · Cited by 145 · see citing works

The Roles of Immune Cells in the Pathogenesis of Fibrosis

Huang, E., Peng, N., Xiao, F., Hu, D., Wang, X., & Lu, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155203 · Cited by 130 · see citing works

‘Repair’ Treg Cells in Tissue Injury

Zhang, C., Li, L., Feng, K., Fan, D., Xue, W., & Lü, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484295 · Cited by 107 · see citing works

Increased peripheral CD4 + regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C

Langhans, B., Nischalke, H. D., Krämer, B., Hausen, A., Dold, L., van Heteren, P., Hüneburg, R., Nattermann, J., Strassburg, C. P., & Spengler, U. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.019 · Cited by 96 · see citing works

Neutrophils in Tissue Injury and Repair: Molecular Mechanisms and Therapeutic Targets

Yang, L., Shi, F., Cao, F., Wang, L., She, J., He, B., Xu, X., Kong, L., & Cai, B. (2025) · MedComm · doi:10.1002/mco2.70184 · Cited by 93 · see citing works

Regulatory T cells (Tregs) in liver fibrosis

Wu, K., Qian, Q., Zhou, J., Sun, D., Duan, Y., Zhu, X., Sartorius, K., & Lu, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01347-8 · Cited by 85 · see citing works

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis

Garbuzenko, D. V. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i12.3662 · Cited by 78 · see citing works

Treg–tissue cell interactions in repair and regeneration

Loffredo, L. F., Savage, T. M., Ringham, O. R., & Arpaia, N. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231244 · Cited by 79 · see citing works

Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type

Langhans, B., Alwan, A. W., Krämer, B., Glässner, A., Lutz, P. L., Strassburg, C. P., Nattermann, J., & Spengler, U. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.038 · Cited by 73 · see citing works

The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix

Matsuda, M., & Seki, E. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111556 · Cited by 64 · see citing works

Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

D’Costa, Z., Jones, K. I., Azad, A. K., van Stiphout, R. G. P. M., Lim, S. Y., Gomes, A. L., Kinchesh, P., Smart, S., McKenna, W. G., Buffa, F. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2833 · Cited by 64 · see citing works

Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade

Bozward, A. G., Warricker, F., Oo, Y. H., & Khakoo, S. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643310 · Cited by 63 · see citing works

Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis

Li, X., Su, Y., Hua, X., Xie, C., Liu, J., Huang, Y., Zhou, L., Zhang, M., Li, X., & Gao, Z. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1167-y · Cited by 60 · see citing works

Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8+ T cell

Xu, F., Wang, X., Huang, Y., Zhang, X., Sun, W., Du, Y., Xu, Z., Kou, H., Zhu, S., Liu, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113424 · Cited by 58 · see citing works

The Space of Disse: The Liver Hub in Health and Disease

Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers · doi:10.3390/livers1010002 · Cited by 57 · see citing works

Interleukin‐8: A critical chemokine in biliary atresia

Dong, R., & Zheng, S. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12900 · Cited by 57 · see citing works

Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways

Lee, K. J., Jang, Y. O., Cha, S., Kim, M. Y., Park, K., Eom, Y. W., & Baik, S. K. (2018) · Gut and Liver · doi:10.5009/gnl17443 · Cited by 56 · see citing works

Adverse outcome pathway development from protein alkylation to liver fibrosis

Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 54 · see citing works

Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation

Gong, W.-G., Jue-long, L., Niu, Q., Wang, H., Zhou, Y., Chen, S., & Liang, G.-W. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.02.017 · Cited by 49 · see citing works

Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis

Zweers, S. J. L. B., Shiryaev, A., Komuta, M., Vesterhus, M. N., Hov, J. R., Perugorria, M. J., de Waart, D. R., Chang, J., Tol, S., Velde, A. A. T., et al. (2016) · Liver International · doi:10.1111/liv.13092 · Cited by 47 · see citing works

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

Medrano, L. M., García‐Broncano, P., Berenguer, J., González‐García, J., Jiménez‐Sousa, M. Á., Guardiola, J. M., Casal, M. C., Quereda, C., Sanz, J., Canorea, I., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001787 · Cited by 47 · see citing works

Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: From occurrence to end stage of disease

Zhang, H., Jiang, Z., & Zhang, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.005 · Cited by 47 · see citing works

An overview of the role of interleukin-8 in colorectal cancer

Najdaghi, S., Razi, S., & Rezaei, N. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155205 · Cited by 46 · see citing works

Immune Cell Migration to Cancer

Ryan, A. T., Kim, M., & Lim, K. (2024) · Cells · doi:10.3390/cells13100844 · Cited by 35 · see citing works

The role of the interleukin family in liver fibrosis

Zhang, Z., Wang, J., Li, H., Niu, Q. F., Tao, Y., Zhao, X., Zeng, Z., & Dong, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1497095 · Cited by 34 · see citing works

Molecular Links between Alcohol and Tobacco Induced DNA Damage, Gene Polymorphisms and Patho-physiological Consequences: A Systematic Review of Hepatic Carcinogenesis

Mansoori, A. A., & Jain, S. K. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.4803 · Cited by 35 · see citing works

Annexin A6 protein is downregulated in human hepatocellular carcinoma

Haberl, E. M., Rein‐Fischboeck, L., Pohl, R., Wanninger, J., Hoy, A. J., Grewal, T., Eisinger, K., Krautbauer, S., Liebisch, G., Weiß, T. S., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2735-9 · Cited by 30 · see citing works

IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses

Han, J. W., Sung, P. S., Hong, S.-H., Lee, H., Koh, J., Lee, H., White, S., Maslow, J. N., Weiner, D. B., Park, S., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.009 · Cited by 29 · see citing works

Chronic Hepatitis C Pathogenesis: Immune Response in the Liver Microenvironment and Peripheral Compartment

Rios, D. A., Casciato, P. C., Caldirola, M. S., Gaillard, M. I., Giadans, C. G., Ameigeiras, B., Matteo, E. N. D., Preciado, M. V., & Valva, P. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.712105 · Cited by 27 · see citing works

Role of regulatory T-cells during hepatitis C infection: From the acute phase to post-transplantation recurrence

Barjon, C., Dahlqvist, G., Calmus, Y., & Conti, F. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.06.014 · Cited by 27 · see citing works

Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis

Wan, M., Han, J., Ding, L., Hu, F., & Gao, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604894 · Cited by 27 · see citing works

Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ‐dependent induction and expansion of regulatory T cells in mice

Khadem, F., Gao, X., Mou, Z., Jia, P., Movassagh, H., Onyilagha, C., GOUNNI, A. S., Wright, M. C., & Uzonna, J. E. (2015) · Hepatology · doi:10.1002/hep.28130 · Cited by 26 · see citing works

Prognostic and Pathophysiologic Significance of IL-8 (CXCL8) in Biliary Atresia

Godbole, N., Nyholm, I., Hukkinen, M., Davidson, J., Tyraskis, A., Eloranta, K., Andersson, N., Lohi, J., Heikkilä, P., Kyrönlahti, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122705 · Cited by 25 · see citing works

Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: based on bioinformatics, transcriptomics and q-PCR experiments

Bai, Y.-M., Liang, S., & Zhou, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133543 · Cited by 25 · see citing works

Progress in Biomarkers Related to Biliary Atresia

Kong, F., Dong, R., Chen, G., Sun, S., Yang, Y., Jiang, J., Meng, L., Chen, H., Zhu, J., & Zheng, S. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00260 · Cited by 23 · see citing works

Inflammatory Network of Liver Fibrosis and How It Can Be Targeted Therapeutically

Lowe, K., Tanase, C. E., Maghami, S., Fisher, L. E., & Ghaemmaghami, A. M. (2023) · Immuno · doi:10.3390/immuno3040023 · Cited by 19 · see citing works

Chronic hepatitis C liver microenvironment: role of the Th17/Treg interplay related to fibrogenesis

Rios, D. A., Valva, P., Casciato, P. C., Frias, S., Caldirola, M. S., Gaillard, M. I., Bezrodnik, L., Bandi, J. C., Galdame, O., Ameigeiras, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13777-3 · Cited by 18 · see citing works

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

Fovet, C.-M., Stimmer, L., Contreras, V., Horellou, P., Hubert, A., Seddiki, N., Chapon, C., Tricot, S., Leroy, C., Flament, J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.052 · Cited by 13 · see citing works

Immune Checkpoints and the Immunology of Liver Fibrosis

Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 14 · see citing works

The Genetic Profile and Serum Level of IL-8 Are Associated with Chronic Hepatitis B and C Virus Infection

Amoras, E. D. S. G., de Brito, W. B., Queiroz, M. A. F., Conde, S. R. S. D. S., Vallinoto, I. M. V. C., Ishak, R., & Vallinoto, A. C. R. (2021) · Biomolecules · doi:10.3390/biom11111664 · Cited by 14 · see citing works

Distinctive intrahepatic characteristics of paediatric and adult pathogenesis of chronic hepatitis C infection

Valva, P., Gismondi, M. I., Casciato, P. C., Galoppo, M., Lezama, C., Galdame, O., Gadano, A. C., Galoppo, M. C., Müllen, E., Matteo, E. N. D., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12728 · Cited by 14 · see citing works

Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer

Sererols-Viñas, L., Garcia‐Vicién, G., Ruiz-Blázquez, P., Lee, T., Lee, Y. A., Gonzalez‐Sanchez, E., Vaquero, J., Moles, A., Filliol, A. A., & Affò, S. (2025) · Seminars in Liver Disease · doi:10.1055/a-2551-0724 · Cited by 12 · see citing works

Ginsenoside, a potential natural product against liver diseases: a comprehensive review from molecular mechanisms to application

Shang, S., Yang, H., Qu, L., Fan, D., & Deng, J. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2451761 · Cited by 11 · see citing works

The −3279C>A and −924A>G polymorphisms in the FOXP3 Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver Diseases

Pereira, L. M. S., Amoras, E. D. S. G., Conde, S. R. S. D. S., Demachki, S., Monteiro, J. C., Feitosa, R. N. M., da Silva, A. N. M. R., Ishak, R., & Vallinoto, A. C. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02014 · Cited by 10 · see citing works

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal

Ghosh, A., Romani, S., Kottilil, S., & Poonia, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207473 · Cited by 10 · see citing works

Between Scylla and Charybdis: The role of the human immune system in the pathogenesis of hepatitis C

Spengler, U. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i44.7852 · Cited by 10 · see citing works

STAT activation in regulatory CD4+ T cells of patients with primary sclerosing cholangitis

Dold, L., Kalthoff, S., Frank, L., Zhou, T., Esser, P. L., Lutz, P. L., Strassburg, C. P., Spengler, U., & Langhans, B. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1248 · Cited by 9 · see citing works

Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis

Kinjo, T., Inoue, H., Kusuda, T., Fujiyoshi, J., Ochiai, M., Takahata, Y., Honjo, S., Koga, Y., Hara, T., & Ohga, S. (2018) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2018.09.005 · Cited by 9 · see citing works

The Effect of FOXP3+ Regulatory T Cells on Infectious and Inflammatory Diseases

Bai, Y., Gao, F., Li, D., Ji, S., Zhang, S., Guo, W., & Li, B. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000070 · Cited by 8 · see citing works

The Role of Melatonin, IL-8 and IL-10 in Intrahepatic Cholestasis of Pregnancy

Çelik, S., GÜVEY, H., Çalışkan, C. S., & ÇELİK, S. (2020) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-1233-9084 · Cited by 7 · see citing works

Glucocorticosteroids administration is associated with increased regulatory T cells in equine asthmatic lungs

Boivin, R., Vargas, A., Cano, P., & Lavoie, J. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.05.010 · Cited by 7 · see citing works

Reversing immune dysfunction and liver damage after direct-acting antiviral treatment for hepatitis C

Mazouz, S., Boisvert, M., Shoukry, N. H., & Lamarre, D. (2018) · Canadian Liver Journal · doi:10.3138/canlivj.1.2.007 · Cited by 6 · see citing works

Genomic variants link to hepatitis C racial disparities

Yeh, M. M., Boukhar, S., Roberts, B., Dasgupta, N., & Daoud, S. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19755 · Cited by 6 · see citing works

Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation

Jiang, X., Kanda, T., Wu, S., Nakamoto, S., Nakamura, M., Sasaki, R., Haga, Y., Wakita, T., Shirasawa, H., & Yokosuka, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131973 · Cited by 5 · see citing works

Preliminary Report of Inflammatory Markers, Oxidative Stress, and Insulin Resistance in Adolescents of Different Ethnicities

Butani, L., Dharmar, M., Devaraj, S., & Jialal, I. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0161 · Cited by 5 · see citing works

Interactions of Stellate Cells with Other Non-Parenchymal Cells

Kawada, N., & Parola, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00012-9 · Cited by 4 · see citing works

CD19+CD24hiCD38hi regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of hepatitis C.

Fang, Q., Deng, Y., Liang, R., Mei, Y., Hu, Z., Wang, J., Sun, J., Zhang, X., Bellanti, J. A., & Zheng, S. G. (2020) · PubMed Central · Cited by 4 · see citing works

Controversy on the role of FoxP3+ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections

Claassen, M. A. A., Janssen, H. L. A., de Knegt, R. J., & Boonstra, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.029 · Cited by 4 · see citing works

Hepatic Fibrosis in Hepatitis C

Sheiko, M. A., & Rosen, H. R. (2016) · Springer eBooks · doi:10.1007/978-4-431-56101-9_3 · Cited by 3 · see citing works

Reply to: “Controversy on the role of FoxP3+ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections”

Langhans, B., & Spengler, U. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.007 · Cited by 3 · see citing works

Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis

Li, Y., Quan, X., Tai, Y., Wu, Y.-T., Wei, B., & Wu, H. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i8.1156 · Cited by 2 · see citing works

Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway

Han, X., Wu, J., Sha, Z., Lai, R., Shi, J., Mi, L., Yin, F., & Guo, Z. (2023) · Clinical Medicine Insights Oncology · doi:10.1177/11795549231161212 · Cited by 2 · see citing works

The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion

Lee, S. E., Jo, M. G., Park, S. W., Kim, H. J., Yun, S. P., & Kim, J.-W. (2026) · Animal Cells and Systems · doi:10.1080/19768354.2026.2630463 · Cited by 2 · see citing works

Cytotoxic NK cells phenotype and activated lymphocytes are the main characteristics of patients with alcohol-associated liver disease

Zurera-Egea, C., Teniente‐Serra, A., Fuster, D., Martínez-Cáceres, E. M., Muga, R., & Zuluaga, P. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01121-1 · Cited by 1 · see citing works

The immunobiology of regulatory T cells in hepatitis B and C

Susilawati, T. N., Permata, A. T., & Setyawan, S. (2019) · AIP conference proceedings · doi:10.1063/1.5139853 · Cited by 1 · see citing works

Functional state of regulatory CD4+T cell pool in HIV/hepatitis C virus coinfected subjects

Сайдакова, Е. В., Korolevskaya, L. B., & Владимирович, Ш. К. (2022) · Russian Journal of Immunology · doi:10.46235/1028-7221-1083-fso · Cited by 1 · see citing works

Chronic Hepatitis C

Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_6 · Cited by 1 · see citing works

The Role of T Regulatory Cells and Pro-and Anti-inflammatory Cytokines in Viral Persistence and Clinical Outcome in HCV-Infected Patients

Heiba, A. A., Dessouki, O., Nemr, N. A., Metwally, L. A., & Gomaa, N. (2015)

Evaluation of IL-8 Level in Hepatitis C Infected Patients : Relation to Combined Peg-Interferon / Ribavirin Treatment Response

Sorour, A. E., Mokhtar, M., & Marie, M. A. E.-A. (2013) · The Egyptian Journal of Medical Microbiology · doi:10.12816/0004971

Controversy on the role of FoxP3 + regulatory T cells in fibrogenesis in chronic hepatitis C virus infections

Sposito, C., & Mazzaferro, V. (2014)

Regulation of Immunity to Visceral Leishmaniasis by Regulatory T cells (Tregs) and Hepatic Stellate Cells (HSCs)

Khadem, F. (2016) · Mspace (University of Manitoba)

Targeting MOG to skin macrophages prevents EAE in macaques through TGFβ-induced peripheral tolerancePreprint

Fovet, C.-M., Stimmer, L., Contreras, V., Horellou, P., Hubert, A., Sediki, N., Chapon, C., Tricot, S., Leroy, C., Flament, J., et al. (2019) · bioRxiv · doi:10.1101/571828

Role of FoxP3+T Regulatory Cells in Chronic HCV and Its Relation to Disease Severity

El-Refaei, K., Zaky, D. S. E., Attia, F. A., Hendy, O. M., & Kawzae, A.-A. M. (2019) · Clinical Medicine and Diagnostics

INFLAMMATORY REACTION OF HEPATITIS C VIRUS IN HCV PATIENTS

Njum, A. A., & Alwan, J. A. (2021) · PLANT ARCHIVES · doi:10.51470/plantarchives.2021.v21.s1.179

The Differences of T-Regulator Cells, Alanine Aminotransferase Serum and Aspartate Aminotranspherase Between Hepatitis B Chronic Patients with and without Liver Fibrosis

Derosa, Y., Zubir, N., & Arnelis, R. (2021) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/2222021116-123

Immunological Changes of HCV and Typhoid Fever Patient

Alwan, J. A., Saeed, Z. F., & Njum, A. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164899

A prospective study on Foxp3+CD25highCD4+ regulatory T cells in chronic hepatitis C infected patients undergoing direct-acting antiviral combination therapy

Ramadan, R. A., & Mohammed, A. (2019) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2019.282703

Hepatite C crônica na fase cirrótica, efeito dos DAAs na histopatologia dos explantes

Pasinato, A. P. B. F. (2023) · doi:10.11606/t.5.2023.tde-01082023-125434

Monoacylglycerol Lipase, a new anti-inflammatory and anti-fibrogenic target in the liver

Chokr, D. (2018) · theses.fr (ABES) · doi:10.70675/6aac5cc4z3085z4939zb6c9ze439b795571f

Reply to: “Controversy on the role of FoxP3+ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections”

Langhans, B., & Spengler, U. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.007 · Cited by 3 · see citing works

Controversy on the role of FoxP3+ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections

Claassen, M. A. A., Janssen, H. L. A., de Knegt, R. J., & Boonstra, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.029 · Cited by 4 · see citing works

343 HUMAN HEPATOCYTE INDOLEAMINE-2,3-DIOXYGENASE CONTRIBUTES TO ANTIVIRAL DEFENSE AND IMMUNE REGULATION IN HEPATITIS C VIRUS INFECTION

Lepiller, Q., Soulier, E., Lambotin, M., Barths, J., Bachellier, P., Stoll‐Keller, F., Baumert, T. F., Liang, T. J., & Barth, H. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)60345-1

Adaptive CD4+ regulatorische T-Zellen regulieren die Fibrogenese durch Produktion von IL–8 bei chronischer Hepatitis C

Langhans, B., Louis, M., Hüneburg, R., Oldenburg, J., Schultze, J. L., Sauerbruch, T., & Spengler, U. (2012) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1295921

345 PERSISTENT HEPATITIS C VIRUS (HCV) INFECTION IMPAIRS HCV-SPECIFIC CYTOTOXIC T CELL REACTIVITY THROUGH Mcl-1/Bim IMBALANCE DUE TO CD127 DOWN-REGULATION

Larrubia, J. R., Lokhande, M., García-Garzón, S., Míquel, J., González-Praetorious, A., & Sanz‐de‐Villalobos, E. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)60347-5